QTEX
Inspira Technologies Oxy B.H.N. Ltd.
NASDAQ · Healthcare · Medical - Specialties · IL
$0.83
+1.85%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-41.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | Parnes Tal · director | A-Award | 550,000 | $0.00 |
| Sep 1, 2026 | Amit Lior · director | A-Award | 170,000 | $0.00 |
| Sep 1, 2026 | Matza Sivan · director | A-Award | 100,000 | $0.00 |
| Sep 1, 2026 | Ben-Noon Dagi Shahar · director, officer: Chief Executive Officer | A-Award | 550,000 | $0.00 |
| Jul 15, 2026 | shabtay abraham · officer: COO | A-Award | 550,000 | $0.00 |
| Jul 14, 2026 | Tehila Yafit · officer: Chief Financial Officer | A-Award | 550,000 | $0.00 |
| Jul 14, 2026 | Rozanovich Yoav · officer: Chief Business Officer | A-Award | 550,000 | $0.00 |
| Jul 14, 2026 | Yechezkely Hayon Daniella · officer: Chief Technology Officer | A-Award | 550,000 | $0.00 |
| Jun 2, 2026 | shabtay abraham · officer: COO and VP of R&D | M-Exempt | 38,095 | $0.12 |
| Jun 2, 2026 | Yechezkely Hayon Daniella · officer: Chief Technology Officer | Sale | 50,000 | $3.00 |
| Jun 2, 2026 | Tehila Yafit · officer: Chief Financial Officer | Sale | 1,900 | $3.51 |
| Jun 2, 2026 | Tehila Yafit · officer: Chief Financial Officer | Sale | 28,100 | $3.50 |
| Jun 2, 2026 | shabtay abraham · officer: COO and VP of R&D | M-Exempt | 95,239 | $3.37 |
| May 29, 2026 | Tehila Yafit · officer: Chief Financial Officer | M-Exempt | 13,605 | $0.12 |
| May 29, 2026 | Tehila Yafit · officer: Chief Financial Officer | Sale | 15,000 | $2.56 |
| May 29, 2026 | Tehila Yafit · officer: Chief Financial Officer | Sale | 16,395 | $2.01 |
| May 29, 2026 | Tehila Yafit · officer: Chief Financial Officer | Sale | 13,605 | $2.03 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 1, 2026